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ABSTRACT Ophthalmia neonatorum, also called neonatal conjunctivitis, acquired
during delivery can occur in the ﬁrst 28 days of life. Commonly caused by the bacte-
rial pathogen Neisseria gonorrhoeae, infection can lead to corneal scarring, perfora-
tion of the eye, and blindness. One approach that can be taken to prevent the dis-
ease is the use of an ophthalmic prophylaxis, which kills the bacteria on the surface
of the eye shortly after birth. Current prophylaxes are based on antibiotic ointments.
However, N. gonorrhoeae is resistant to many antibiotics and alternative treatments
must be developed before the condition becomes untreatable. This study focused
on developing a fatty acid-based prophylaxis. For this, 37 fatty acids or fatty acid de-
rivatives were screened in vitro for fast antigonococcal activity. Seven candidates
were identiﬁed as bactericidal at 1 mM. These seven were subjected to irritation
testing using three separate methods: the bovine corneal opacity and permeability
(BCOP) test; the hen’s egg test—chorioallantoic membrane (HET-CAM); and the red
blood cell (RBC) lysis assay. The candidates were also tested in artiﬁcial tear ﬂuid to
determine whether they were effective in this environment. Four of the candidates
remained effective. Among these, two lead candidates, monocaprin and myristoleic
acid, displayed the best potential as active compounds in the development of a
fatty acid-based prophylaxis for prevention of ophthalmia neonatorum.
IMPORTANCE Ophthalmia neonatorum is a painful bacterial infection of the eye in
newborns. A common cause is Neisseria gonorrhoeae, which has the potential to
cause severe damage to the eye and blindness. This study was designed to identify
new and unconventional drug candidates that could be used in an eye ointment to
prevent the development of this disease. The drugs that were tested were fatty
acid-based compounds. The potential candidates were screened for their ability to
kill bacteria in tear ﬂuid without causing damage to the eye. This study identiﬁed
seven candidates that are fast acting and nonirritating, with two strong candidates
for potential use in the eye. Further development and testing are now required to
formulate an eye treatment incorporating these drugs to prevent ophthalmia neona-
torum.
KEYWORDS antibiotic resistance, eye infection, fatty acids, gonococcus
Ophthalmia neonatorum is the term used to describe conjunctivitis occurring during
the ﬁrst 28 days of life; the condition is also referred to as neonatal conjunctivitis (1).
The disease is characterized by inﬂammation of the eye with swelling of the eyelids and
a purulent yellowish discharge from the closed eye. The infection may start in one eye
and then progress to the contralateral one. If left untreated, or if standard treatment
fails, the infection can cause corneal scarring or corneal perforation which can result in
permanent blindness (2). The disease is caused by transfer of infectious agents from the
mother to the eyes of the neonate during passage though the birth canal (3), with the
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two most common etiological agents being Neisseria gonorrhoeae and Chlamydia
trachomatis. Gonococcal ophthalmia neonatorum commonly has a faster onset than
C. trachomatis ophthalmia neonatorum and is usually more aggressive (4). The expect-
ant mother may not know that she harbors N. gonorrhoeae. Between 2001 and 2006,
more than 50% of the women that attended selected genitourinary medicine clinics in
England and Wales had no symptoms of N. gonorrhoeae infection (5).
The disease can be controlled in three ways: selective treatment of expectant
mothers via prenatal screening; blanket prenatal antimicrobial treatment of all expect-
ant mothers; and postnatal application of prophylaxis to all neonates within the ﬁrst
few hours after birth.
Postnatal prophylaxis can be applied in the form of an eye drop or eye ointment.
Current prophylaxes include 1% tetracycline and 0.5% erythromycin ophthalmic oint-
ments. However, the use of tetracycline-based ophthalmic ointments is in decline due
to concerns over resistance. The prophylaxis previously used was 1% to 2% aqueous
silver nitrate; however, its use was discontinued due to chemically induced neonatal
conjunctivitis and ocular toxicity (6). The United States Preventive Services Task Force
has classiﬁed the use of an ocular prophylaxis for prevention of ophthalmia neonato-
rum as “grade A,” which means that there is high certainty that the net beneﬁt is
substantial (7). They recommend that all newborns are given a prophylaxis within 24 h
of birth. However, in the United Kingdom there has been no prophylaxis since the
1950s and, currently, prenatal screening via assessment of risk factors is used (8).
Since 2008, gonorrhea diagnoses in England have increased year after year and
doubled between 2008 and 2013 (9). There were 29,291 new gonorrhea diagnoses in
England in 2013. Moreover, antimicrobial resistance is a major concern with N. gonor-
rhoeae, with isolates emerging that are multidrug resistant (10). Third-generation
cephalosporins are the recommended antimicrobials, in combination with azithromy-
cin; however, the ﬁrst resistant isolates were reported in 2011 (11). Since then, resistant
isolates have been reported in North America and Europe (12, 13). In 2009, levels of
resistance to penicillin, tetracyclines, and ciproﬂoxacin in England and Wales were 22%,
68%, and 35%, respectively (14).
The antimicrobial properties of certain fatty acids and fatty acid derivatives have
been known for some time (15–17). Research on the antimicrobial effects of fatty acid
on N. gonorrhoeae has also been published (18). A novel ocular prophylaxis for the
prevention of ophthalmia neonatorum based on a fatty acid or fatty acid derivative
would offer an alternative to current prophylaxes in the face of increasing resistance
concerns. Blindness was a signiﬁcant concern with gonococcal ophthalmia neonatorum
before the introduction of antibiotics, with 3% of affected babies suffering permanent
blindness (8). In 1880, before the advent of antibiotics, up to 79% of children in
institutions for the blind had suffered from gonococcal ophthalmia neonatorum (18).
We have to prepare ourselves now with treatment options to serve as alternatives to
common antimicrobials.
RESULTS
Screening of the organic acids. To ﬁnd potential candidates, 37 organic acids,
esters, and salts were tested in a two-tiered screening process. These candidates were
chosen based on the carbon chain lengths of the fatty acids, the presence or absence
of saturation, and modiﬁcations to represent a diverse selection of organic acid
candidates. The ﬁrst screen aimed to determine the ability of each compound to inhibit
the growth of N. gonorrhoeae strain NCCP11945 at 1 mM in GC solid media (Table 1).
This strain was chosen due to its relatively recent isolation, its antibiotic resistance
proﬁle, and the availability of a complete genome sequence. Those candidates able to
inhibit the growth of N. gonorrhoeae strain NCCP11945 were investigated in a second
assay. The second assay tested the ability of each compound to cause at least a
4-log reduction in viable bacteria at 1 mM with a 2-min exposure time (Table 1).
Those candidates able to reduce the number of viable bacteria in this short time
period are promising antigonococcal agents. This process identiﬁed the following
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seven candidates that had strong bactericidal properties: lauric acid; tridecanoic
acid; myristoleic acid; palmitoleic acid; linolenic acid; monocaprin; and sodium
dodecanoate.
Measurement of bactericidal action of the fatty acids. The seven candidates were
further tested against nine gonococcal isolates, including strain NCCP11945 and eight
isolates from Public Health England, to ﬁnd their minimal bactericidal concentration
(MBC). This was deﬁned as the lowest concentration tested to give an average 4-log10
reduction in bacterial count after a 2-min exposure. Myristoleic acid, palmitoleic acid,
linolenic acid, and monocaprin performed well with an MBC of 0.5 mM (Table 1).
Lauric acid, tridecanoic acid, and sodium dodecanoate had an MBC of 0.75 mM.
Figure 1 displays the log reduction graphs for each of the seven candidates tested
TABLE 1 Investigation of antigonococcal properties of organic acids
Chemical class Organic acida
Growth
inhibitionb
Log reduction
at 1 mMc
MBC
(mM)d
Saturated fatty acids Caprylic/octanoic acid (8:0) No
Capric acid/decanoic acid (10:0) No
Undecanoic acid (11:0) Yes No; 0.2
Lauric acid (12:0) Yes Yes; >6 0.75
Tridecanoic acid (13:0) Yes Yes; >6 0.75
Myristic acid (14:0) Yes No; 1.5
Pentadecylic acid (15:0) Yes No; 0.5
Palmitic acid (16:0) No
Heptadecylic acid (17:0) No
Stearic acid (18:0) No
Monounsaturated fatty acids Myristoleic acid (14:1); c9 Yes Yes; >6 0.5
Palmitoleic acid (16:1); c9 Yes Yes; >6 0.5
Oleic acid (18:1); cΔ9 Yes No; 1.0
Elaidic acid (18:1); tΔ9 Yes No; 0.5
Petroselinic acid (18:1); cΔ6 No
trans-Vaccenic acid (18:1); tΔ11 No
cis-Vaccenic acid (18:1); cΔ11 No
Erucic acid (22:1); cΔ13 Yes No; 0.0
Polyunsaturated fatty acids Sorbic acid (6:2); tΔ2,4 No
Linoleic acid (18:2); cΔ9,12 Yes No; 1.6
Linolenic acid (18:3); c9,12,15 Yes Yes; >6 0.5
Arachidonic acid (20:4) cΔ5,8,11,14 Yes NT
Monoglycerides 1-octanoyl-rac-glycerol (C8MG) Yes No; 0.0
Monocaprin (C10MG) Yes Yes; >6 0.5
Monolaurin (C12MG) Yes No; 3.4
Monomyristin (C14MG) Yes No; 0.6
Dicarboxylic acids Succinic acid No
Adipic acid No
Pimelic acid No
Suberic acid No
Azelaic acid No
Sebacic acid No
Ricinoleic acid Ricinoleic acid Yes No; 3.5
Esters Isopropyl myristate No
Isopropyl palmitate No
Fatty acid sodium salt Sodium dodecanoate Yes Yes; >6 0.75
Sodium myristate Yes No; 0.5
aThe common name for each organic acid is listed, as well as the commonly used numerical identiﬁcation of fatty acids based on carbon chain lengths. Bold
highlights the top candidates.
bN. gonorrhoeae strain NCCP11945 did or did not grow on GC agar media containing a 1 mM concentration of the candidate.
cData represent the calculated log reduction in the level of viable bacteria after exposure to a 1 mM concentration of the candidate for 2 min. NT, not tested.
dMinimum bactericidal concentration (MBC) data were estimated as the lowest concentration to give a mean log reduction value above 4 from a 2-min exposure
time.
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against the nine isolates investigated. Any candidate that killed all gonococcal cells
in the cell suspension was given a log reduction score of six. Lauric acid, myristoleic
acid, monocaprin, and sodium dodecanoate tested at 1 mM killed all gonococcal
cells for all isolates. However, palmitoleic acid, linolenic acid, and tridecanoic acid
did not. Two gonococcal isolates in particular displayed some tolerance of palmi-
toleic acid and linolenic acid and were not completely inhibited by these com-
pounds at 1 mM.
Log reductions of selected fatty acids in artiﬁcial tear ﬂuid. The antigonococcal
properties of the seven selected fatty acids were tested in artiﬁcial tear ﬂuid, which
contained calcium chloride. The addition of 1 mM lauric acid, tridecanoic acid, or
sodium dodecanoate gave no reduction in bacterial cell number after exposure, in
contrast to the results seen when they were tested in culture medium (Fig. 2). The tear
ﬂuid was also made without calcium chloride, and the antigonococcal properties of
these fatty acids were completely restored (Fig. 2), indicating that calcium was having
an inhibitory effect upon the candidates. This was most likely due to the negative effect
of calcium on the aqueous solubility of these candidates.
Ocular irritation assays. The summary of the irritation assays is given in Fig. 3. The
hen’s egg test—chorioallantoic membrane (HET-CAM) assay is an acceptable conjunc-
tival model, and the bovine corneal opacity and permeability (BCOP) assay addresses
corneal irritation potential (19–21). The seven candidates did not cause signiﬁcant
damage to the surface of the cornea as judged by ﬂuorescein staining and histological
examination (Fig. 4). Each of the organic compounds was tested on three separate
occasions, and only linolenic acid, monocaprin, and sodium dodecanoate gave any sign
FIG 1 Log reduction assays conducted in culture medium with (A) unsaturated carbon chain fatty acids,
and (B) saturated carbon chain fatty acids and fatty acid derivatives. Mean log reductions ( standard
deviations [SD]) are shown for each of the seven candidates assayed against nine different gonococcal
isolates. The maximum value for the log reduction was 6, so compounds with this value effectively killed
all bacteria in the sample. The common name for each organic acid is used, as well as the commonly used
numerical identiﬁcation of fatty acids based on carbon chain lengths.
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of ﬂuorescein staining. This staining occurred around the area where the rubber
application ring was placed. However, the mean cumulative BCOP scores of these
compounds were lower than 0.5, classing them as nonirritants.
The samples were all tested on the HET-CAM at 1 mg/ml, providing a range of
3.6 mM for linolenic acid to 5 mM for lauric acid. As all candidates were bactericidal at
1 mM, these concentrations were used to demonstrate that these candidates would be
safe to use. Results from the controls and an example of a tested candidate are
illustrated in Fig. 5.
The red blood cell (RBC) assay is a more general irritation assay, investigating lysis
of red blood cells as an assay for lipid bilayer disruption. The longer unsaturated fatty
acids, palmitoleic acid and linolenic acid, required the smallest amount to cause 50%
hemolysis (H50), and their H50 concentrations were lower than their minimum bacte-
ricidal concentration (MBC) (Fig. 3). Tridecanoic acid did not cause any hemolysis even
at the highest concentration tested. The 12-carbon unsaturated sodium salt sodium
dodecanoate gave results similar to those seen with lauric acid. Tridecanoic acid,
myristoleic acid, monocaprin, and lauric acid all had H50 concentrations greater than
their MBCs.
Cell culture model of infection. Because of its potency, resistance to precipitation
in the presence of calcium, and nonirritant nature, monocaprin was chosen from the
seven candidates to test in a cell culture model with a 2-fold dilution series from 1 mM
to 0.125 mM. Bacteria were also challenged with this compound at two different time
points, i.e., at the time of the inoculation and 90 min later. Monocaprin killed all
N. gonorrhoeae bacteria in coculture with human corneal epithelial cells even after the
90 min of infection (Fig. 6). There was a slight difference in the level of efﬁcacy when
monocaprin was used at sub-MBC levels and added 90 min after bacterial inoculation
in comparison to addition immediately after inoculation of the bacteria (Fig. 6). This was
possibly due to monocaprin hindering attachment of the bacterial cells to the corneal
cells when it was added at the time of infection.
The mean log reduction results obtained in cell culture (Fig. 6) were similar to those
obtained in bacterial cell suspensions (Fig. 2). This suggests that the action of mono-
caprin is concentration dependent, rather than time dependent, as the action of the
drug during a 3-h exposure appeared similar to that seen in the original 2-min log
reduction experiments.
When the drug was employed at 1 mM, there was no difference in the mean log
reduction between addition of the drug at the time of infection and addition 90 min
FIG 2 Log reductions in tear ﬂuid without or with calcium (1 mM). Calcium present in the artiﬁcial tear
ﬂuid inactivated the antimicrobial effects of lauric acid (12:0), sodium dodecanoate (12:0Na), and
tridecanoic acid (13:0). The calcium ions also affected palmitoleic acid (16:1) and linolenic acid (18:3) but
to a lesser extent. Myristoleic acid (14:1) and monocaprin (C10MG) were unaffected by the presence of
calcium in the artiﬁcial tear ﬂuid.
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FIG 3 Summarized results of the irritation assays. (A) BCOP assay; 0.5 M NaOH and acetone were irritant controls,
whereas saline solution was a nonirritant control. All candidates were nonirritants based on cumulative scores. (B)
HET-CAM assay; 0.1 M NaOH, acetone, and propane-1,2-diol were irritant controls, and saline solution was a
nonirritant control. In all cases, hyperemia, hemorrhage, and clotting/coagulation were scored. All candidates
(Continued on next page)
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later, both demonstrating complete killing of N. gonorrhoeae. At 0.125 mM, how-
ever, the drug was completely ineffective at both time points. Bacterial log reduc-
tions showed that the concentrations of 0.25 and 0.5 mM were more effective at
0 min.
Cells exposed to the drug candidate and the controls were also assessed via
ﬂuorescence microscopy (Fig. 7). Comparing the images of the noninfected control and
noninfected treated control, it appears that the monocaprin had a minor effect on the
morphology of the cells. Corneal cells treated with 1 mM or 0.5 mM monocaprin
appeared to be less spread and more spherical; this was not observed at lower drug
concentrations (data not shown).
LIVE/DEAD staining of the corneal cells with and without infection revealed that the
infection control samples contained a mixture of live and dead N. gonorrhoeae bacteria
(Fig. 8), as would be expected from an inoculum generated from an overnight culture.
In contrast, infected corneal cells that had been treated with monocaprin and subjected
to LIVE/DEAD staining showed only dead bacterial cells (Fig. 8). These results give a
clearer indication of the impact of the presence of monocaprin on the survival of the
bacteria in a cellular model system than the results obtained with ﬂuorescence micros-
copy alone.
FIG 3 Legend (Continued)
scored zero. (C) Combined results of assays of the RBC lysis, the concentration to lyse 50% of RBCs (H50), and the
minimum bactericidal concentration (MBC) from Table 1. Tridecanoic acid did not lyse RBCs at any concentration
investigated. Two candidates had MBC concentrations greater than their H50 results. Abbreviations: lauric acid
(12:0); tridecanoic acid (13:0); myristoleic acid (14:1); palmitoleic acid (16:1); linolenic acid (18:3); monocaprin
(10:0MG); and sodium dodecanoate (12:0Na).
FIG 4 Unstained and ﬂuorescein-stained bovine eyes exposed to components used in the BCOP test.
Positive controls for irritation (sodium hydroxide and acetone) indicate the opacity of the cornea, and
staining reveals changes in permeability. Histology micrographs (right) show hematoxylin and eosin
(H&E)-stained sections of the epithelial layer of the cornea. Positive controls show extensive cytopathic
damage to the epithelial cell layer, with complete detachment in the case of sodium hydroxide. The
negative control with nonirritating saline solution and all of the candidate organic acids showed no
opacity of the cornea, no notable staining with ﬂuorescein, and no damage to the tissues revealed by
histology. Images for sodium dodecanoate are shown as an example for all candidates. The scale shown
on the histology images is equivalent to 100 m.
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DISCUSSION
Among thirty-seven potential candidates included in the initial screen, seven can-
didate organic acids were found to have potent antimicrobial properties against
N. gonorrhoeae. These were lauric acid, tridecanoic acid, myristoleic acid, palmitoleic
FIG 5 Photographs from HET-CAM test. Eggs were grown for 9 days, and then the tested
components were spotted onto the chorioallantoic membrane for 5 min. The top six images show
positive controls where the irritants caused hyperemia and clotting at the site of application upon
comparison before application (left) and 5 min after application (right). These changes were not seen
in the negative control when saline solution was applied or in the tested candidates, where
application did not cause a reaction. Application of lauric acid (12:0) is shown in the bottom pair of
images as an example for all candidates.
FIG 6 Log reduction of levels of Neisseria gonorrhoeae attached to human cornea epithelial cells when
monocaprin was added immediately after the bacteria or 90 min after infection. Monocaprin delivered
at 1 mM killed the bacteria even when added 90 min after inoculation. Mean log reductions are shown
(SD; n  3).
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acid, linolenic acid, monocaprin, and sodium dodecanoate. These seven fatty acids
were tested in three irritation assays, using two gold standards for ocular drug therapy
development, i.e., the BCOP assay and HET-CAM (19–21), and a more general RBC lysis
assay (22), which may be less informative for development of ocular therapies. All seven
candidates were shown to be effective in two of these assays (the BCOP assay and
HET-CAM; Fig. 2), while ﬁve candidates were shown to be effective in the third test as
well (the RBC lysis assay; Fig. 2). The MBC values for palmitoleic acid and linolenic acid
were greater than their H50 values. However, it is unclear whether the values of the RBC
lysis assay and the MBC are directly comparable. The RBC lysis assay is done by
incubating the RBC with the candidate for 1 h, whereas the log reductions, used to
estimate the MBC, employ a 2-min exposure regimen. Palmitoleic acid and linolenic
acid also had not performed as well as the other candidates in the log reductions
against all of the N. gonorrhoeae isolates.
Log reduction assays conducted in artiﬁcial tear ﬂuid revealed that the saturated
fatty acids lauric acid, tridecanoic acid, and sodium dodecanoate were ineffective in the
presence of calcium ions. The inhibition of the antimicrobial effects of fatty acids by
FIG 7 Immunoﬂuorescent staining of human corneal epithelial cells with and without Neisseria gonor-
rhoeae infection. (A to D) Controls used were noninfected (A); noninfected and treated (with 1 mM
monocaprin) (B); the infection control (C); and gentamicin treated (D). (E and F) The results presented in
panels A to D were compared to results from wells treated with the drug candidate monocaprin at 1 mM
(E) and 0.5 mM (F). Cellular actin was stained with phalloidin-Fluor 488 (green); Neisseria gonorrhoeae cells
were stained with antigonococcal primary antibody and Alexa Fluor 555 secondary antibody (red); nuclei
are stained with DAPI (blue). Images are representative of results observed in two experiments.
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calcium ions was reported previously but could be limited by lowering the pH (23, 24).
However, it is not recommended to have a low pH in an ocular formulation and the
saturated fatty acids were therefore excluded from further analysis. After testing was
performed in artiﬁcial tear ﬂuid and irritation assays, the two best candidates high-
lighted for further development were monocaprin and myristoleic acid.
Use of a cell culture to model N. gonorrhoeae infection is well established (25). The
cell culture work in this study demonstrates that monocaprin at 1 mM killed the
gonococcal cells even when added after 90 min. For any drug candidate to be effective
in a prophylaxis, it must clear the infectious agent from the surface of the eye. Most
prophylaxes for ophthalmia neonatorum are applied in the ﬁrst hour after birth. To be
sure that a candidate could be used in a prophylaxis, the candidate must be able to kill
the bacterial cells after the bacteria have had sufﬁcient time to infect cells of the human
eye. Importantly, in the current research, monocaprin was capable of killing N. gonor-
rhoeae bacteria even after they had infected the corneal cells for 90 min. Monocaprin
had been reported previously to have strong antigonococcal properties (18), but
myristoleic acid had not been tested. However, myristoleic acid was found to be
ineffective against C. trachomatis, while monocaprin has again been shown to be
bactericidal (26). Thus, monocaprin would have the advantage of being active against
other causes of ophthalmia neonatorum. Monocaprin has also reportedly been used to
make hydrogel-based formulations and has been proposed for the treatment of cold
sores and as protection against sexually transmitted infections (27–29). Monocaprin-
based hydrogels have been used in a mouse model for protection against herpes
simplex virus 2 infection (29), and no irritation of the mouse vaginal mucosa was
observed upon application of the hydrogel. Monolaurin has been shown to be a
powerful anti-Staphylococcus aureus agent and has been tested as an additive to
tampons in trials to control S. aureus growth to prevent exotoxin production (30).
FIG 8 LIVE/DEAD staining of gonococcus-infected human corneal epithelial cells. Live bacteria appear
green, while dead cells appear red. (A and B) Untreated infection control samples. (C and D) Human
corneal epithelial cells infected and treated with 1 mM monocaprin. The untreated infection control
sample had many green-staining live bacteria and a few dead bacteria stained red (A and B), whereas the
monocaprin-treated samples contained only red-stained dead bacterial cells, some of which were still
attached to the human corneal epithelial cells (C and D). Some green structures also appear in the treated
samples, but these are likely to represent cell debris that was void of nuclear material stained by the red
propidium iodide, giving the red appearance to dead bacterial cells. No viable bacteria were recovered
from these wells. Images are representative of results observed in two experiments.
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Antimicrobial resistance did not develop even after continuous passage on sublethal
concentrations of monolaurin for a year (31).
The mechanism of action of monocaprin and myristoleic acid is unknown, but it has
been suggested to involve cell membrane disruption (16–18). This would explain why
these candidates caused lysis of RBCs. However, some candidates had MBCs far below
their H50 results. This mechanism of action would have the added advantage that it is
unlikely that the bacteria would develop resistance. Added to this is the way in which
the infection develops, with neonatal ocular infections occurring after inoculation of
the eyes during birth. Not only does prophylaxis to prevent ophthalmia neonatorum
occur before bioﬁlm formation, but also dispersion of bioﬁlms by fatty acids has been
shown previously (32). N. gonorrhoeae does possess at least two efﬂux systems (the
mtrCDE and farAB systems) that can transport hydrophobic molecules out of the cell
(33, 34). However, despite N. gonorrhoeae strain NCCP11945 possessing these efﬂux
systems, it was unable to transport these fatty acids outside the cell quickly enough to
prevent membrane lysis.
Fluorescence microscopy revealed that the higher concentrations of monocaprin
inﬂuenced the morphology of the corneal cells. Morphology changes due to exposure
to high levels of monocaprin have previously been reported (16, 35). However, one
study that looked at the effect of 1.3 mM monocaprin exposure on the permeability of
a Caco-2 monolayer demonstrated that the cells returned to normal after 30 h (35).
N. gonorrhoeae cells remain visible in ﬂuorescence microscopy after treatment; how-
ever, LIVE/DEAD staining clearly demonstrated that all of the gonococci had stained
red, indicating that they were killed by the treatment with monocaprin (Fig. 8).
To fully establish whether monocaprin or myristoleic acid or both can be used in an
ocular formulation to prevent ophthalmia neonatorum, the safety of these compounds
has to be evaluated. Three irritation assays have been competed in this study, but an
in vivo test will have to be conducted to be sure that no irritation occurs. There is no
doubt that these two candidates have powerful antimicrobial properties that are stable
in tear ﬂuid, but their effectiveness on the surface of the eye needs to be fully
evaluated.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The well-characterized N. gonorrhoeae NCCP11945 strain
(36) was used in the screening stage. Eight isolates obtained from Public Health England, representing
circulating isolates from various European locations, were used in the log reduction assays. All isolates
were cultured for 24 h prior to testing by plating on GC solid medium (Oxoid Limited, Hampshire, United
Kingdom) with Kellogg supplements and incubation at 37°C and 5% CO2 (37).
Chemicals. A list of all the organic acids tested in this study is presented in Table 1. The tested
compounds include saturated and unsaturated fatty acids, monoglycerides, dicarboxylic acids, and fatty
acid sodium salts. All compounds investigated were resuspended at 100 mM in ethanol unless stated
otherwise. All chemicals were obtained from Sigma-Aldrich (Poole, Dorset, United Kingdom).
Measurement of bactericidal action of selected fatty acids. Log reductions were done as
described by Bergsson and coworkers (18). Brieﬂy, cells were suspended in GC broth (18 g/liter GC base
[Oxoid, Limited] with added deﬁned supplements) to an optical density at 520 nm of 0.3, which is
approximately equivalent to 107 to 108 cells per ml (38). The suspension (500 l) was then added to 5 l
of each 100 mM fatty acid stock to give a ﬁnal assay concentration of 1 mM or to 5 l of ethanol (vehicle
control). The contents of the tubes were then mixed at room temperature for 2 min and immediately
diluted in a 10-fold dilution series to 104. The dilutions were plated by spreading 10 l on a quarter of
a plate; a 100-l neat solution was also plated. Plates were then incubated at 37°C for 48 h, with all
samples plated in duplicate. A reduction in viable cell count by more than 4 log10 was deemed
bactericidal, and the compound responsible was selected for further investigation. Bactericidal com-
pounds were then tested at 0.75, 0.5, and 0.25 mM, with 0.125 mM also used for some potent
compounds, to establish the minimum bactericidal concentration. Additional testing at lower concen-
trations was also done on the eight clinical isolates of European origin.
Bovine corneal opacity and permeability (BCOP) test. Bovine eyes were collected from a local
slaughter house (ABP, Guildford, Surrey, United Kingdom) and were transported in cold saline solution
for testing at the laboratory. Each eye was ﬁrst visually examined for signs of damage before use. The test
was conducted as detailed by Abdelkader and coworkers (21). The exposure time of the test substances
was 30 s. The selected bactericidal compounds were tested at 1 mM in saline solution, with a
corresponding vehicle control (1% ethanol–saline solution) also performed. A medium irritant of 100%
acetone and a strong irritant of 0.5 M sodium hydroxide were also used as controls in each experiment.
The test area of the cornea was then washed with 10 ml saline solution. Corneal damage to the test area
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was assessed by ﬂuorescein staining and examination under a cobalt blue ﬁlter. Pathological scoring
based on opacity, epithelial integrity, and epithelial detachment was done in accordance with previous
publications (19). Each of the seven lead candidates was tested in triplicate, and each test was performed
on a separate day using a different batch of eyeballs. Corneal histology was done as outlined by
Abdelkader and coworkers (21) by evaluating the damage to the epithelial layer and stroma of the cornea
after hematoxylin and eosin staining.
Hen’s egg test—chorioallantoic membrane (HET-CAM). The HET-CAM was performed as de-
scribed by Alany and coworkers (20). Fertilized white leghorn eggs (Henry Stewart and Co. Ltd.,
Fakenham, Norfolk, United Kingdom) were checked for damage and incubated at 37°C with 60% to 70%
relative humidity. At day 4, the eggs were removed from their shells and placed in incubation chambers.
At day 9, the CAMs were tested. This was done by applying 200 l of the testing material and monitoring
inﬂammatory responses at 30, 120, and 300 s. At each of these time points, the conjunctival irritation
potential of the test substance on the CAMs was evaluated by assessing them against the published
scoring system (20).
Red blood cell (RBC) lysis assay. Whole bovine blood was obtained from a local slaughter house
(ABP), adding 90 ml blood to 10 ml 110 mM trisodium citrate anticoagulant. RBCs were isolated the same
day. The RBCs were washed by three repeats of centrifugation (1,500  g for 10 min) and resuspension
in phosphate-buffered saline (PBS) with 10 mM glucose (PBSG). Testing was done following the
guidelines of the European Union Reference Laboratory for alternatives to animal testing (EURL-ECVAM)
(22). The organic acids were solubilized in dimethyl sulfoxide (DMSO) and diluted to a maximum DMSO
concentration of 10%. In a 2-ml centrifuge tube, 750 l of the sample was added to 250 l RBCs. Controls
used in the assay were a complete lysis control (deionized water) and a fragility control (PBSG–10%
DMSO). Samples were shaken at room temperature for 1 h and then centrifuged at 14,000  g for 2 min.
An aliquot of 750 l of the supernatant was taken and its absorbance at 451 nm measured.
Testing in artiﬁcial tear ﬂuid. Artiﬁcial tear ﬂuid was made as described by Mirejovsky and others
(39) with or without calcium chloride. The fatty acid candidates were tested in artiﬁcial tear ﬂuid to
demonstrate that they could kill the bacteria in this environment. As with the previous log reductions,
107 gonococcal cells (isolate NCCP 11945) were suspended in GC broth. The cell suspension was
centrifuged to remove the culture medium, and the bacteria were resuspended in the tear ﬂuid. This was
then added to the concentrated organic acid candidates. The cells were then enumerated again after
2 min of exposure to estimate any reduction in cell number due to the exposure to the organic acid.
Cell culture infection model. Primary cornea epithelial cells (Life Technologies, Inc.) were grown in
keratinocyte serum-free medium (Life Technologies, Inc.) at 37°C with 5% CO2 until 80% conﬂuence was
reached. Cells were treated with trypsin, washed, added to 24-well plates, and incubated for a further
24 h. The medium was replaced and approximately 107 CFU/ml P and Opa N. gonorrhoeae strain
NCCP11945 added to reach a host-to-pathogen ratio (multiplicity of infection) of 1:10. Monocaprin
(1 mM, 0.5 mM, 0.25 mM, or 0.125 mM) was added either at 0 min or at 90 min after seeding with
N. gonorrhoeae. Controls included noninfected, noninfected treated (with 1 mM monocaprin), infection,
and gentamicin controls. After 3 h, the cells were washed, treated with 1% saponin, and incubated for
10 min at 37°C. GC broth was added to each well, and log reductions were calculated as detailed above.
Comparisons of the log reductions at different drug administration times at given concentrations were
performed using an unpaired t test and GraphPad Prism (version 6.01).
For microscopy, cells were grown in 24-well plates containing 13-mm-diameter round glass cover-
slips and were treated as described above. After washing, cells were ﬁxed in 4% paraformaldehyde for
20 min, washed in PBS, and blocked with 5% bovine serum albumin–PBS for 30 min. After washing was
performed, rabbit polyclonal IgG antigonococcal antibody (Abcam, Inc.) (1/400 in PBS) was added and
the reaction mixture was incubated at 4°C overnight. Wells were washed, goat polyclonal anti-rabbit-IgG
conjugated to Alexa Fluor 555 (1/500) and phalloidin-Fluor 488 (Abcam, Inc.) (1/1,000) was added for 1 h,
and then the reaction mixture was washed and mounted with Fluoroshield mounting medium with
4=,6-diamidino-2-phenylindole (DAPI) (Abcam, Inc.). Slides were viewed using a Nikon Eclipse i80 ﬂuo-
rescence microscope (Nikon United Kingdom) and images captured using standard DAPI, tetramethyl
rhodamine isocyanate (TRITC), and TRITC ﬁlters and NIS-Elements BR 3.0 SP7 (Nikon United Kingdom)
software. The images were later merged using ImageJ (40).
LIVE/DEAD staining. The LIVE/DEAD BacLight bacterial viability kit for microscopy (Life Technolo-
gies, Inc.) was used according to manufacturer’s instructions. After the course of infection, the culture
wells were washed ﬁve times with sterile 0.85% NaCl to remove nonadhered bacterial cells. Stain was
added to each well for 15 min at room temperature before washing in 0.85% saline solution was
performed. Glass coverslips were mounted in BacLight mounting oil and visualized on a Nikon Eclipse i80
ﬂuorescence microscope (Nikon United Kingdom) as detailed above.
Ethics statement. Fertilized white leghorn eggs for medical research were purchased from Henry
Stewart and Co. Ltd. (Fakenham, Norfolk, United Kingdom). The eggs were used at day 4 and at day 9.
In accordance with United Kingdom and EU ethics guidelines, experiments were terminated before day
10 of embryonic development and thus did not require licensing or approvals.
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